Bringing Cancer Into Focus: Biomarkers & Precision Medicine

What if the key to treating cancer was hiding in plain sight – written into its DNA? In this episode of Science Will Win, host Dr. Raven Baxter explores one of the most exciting breakthroughs in cancer care today: the discovery of biomarkers. These tiny molecular signals are helping doctors understand what’s really driving an individual person’s cancer – and opening the door to treatments that can dramatically change patient outcomes.

You’ll hear powerful stories from people whose cancers were traced back to a specific biomarker, alongside experts who break down what biomarker testing is, how it works, and why it’s transforming the way we think about cancer treatment.   

Biomarkers are showing us that when we understand cancer at its molecular level, a disease that once felt like an unsolvable mystery starts to come into focus.

Featured guests:
– Dr. Ross Camidge, Director of Thoracic Oncology, University of Colorado
– Kelly Huffman, Lung Cancer Patient and Retail Account Manager, Pfizer
– Karin Tollefson, Chief Oncology Medical Officer, Pfizer

Dive into the episode here:
00:00 – An oncologist’s diagnosis introduces the world of biomarker
03:10 – Defining biomarkers and its history
06:24 – Discovery of the first lung cancer biomarker
08:39 – The start Kelly’s lung cancer journey
16:00 – Biomarkers: how do you test for them?
19:11– Discovery of ALK biomarker shift’s Kelly’s story
22:34 – Landscape of targeted therapy and lung cancer today
25:24 – Moving forward with targeted treatments and conclusion

Check out our YouTube channel (@Pfizer) to watch the full interview with Raven & Kelly Huffman on her lung cancer journey.

Season 6 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time.

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.